Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Saltz

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 23, 2008
NCCN Task Force Report: Oral chemotherapySaul N Weingart, Elizabeth Brown, Peter B Bach, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Journal of the National Cancer Institute|August 3, 2023
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancerHagen F Kennecke, Rebecca Auer, May Cho, et al.
Surgical Endoscopy|July 14, 2025
The value of MRI and flexible sigmoidoscopy in detecting tumor regrowth in watch and wait rectal cancer patients undergoing active surveillance after total neoadjuvant therapyTrevor M Yeung, Roni Y Rosen, Aron Bercz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Occult primary cancer clinical practice guidelinesDavid S Ettinger, Juan P Arnoletti, Jon P Gockerman, et al.
Clinical Colorectal Cancer|November 8, 2011
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancerLeonard Saltz, Suprith Badarinath, Shaker Dakhil, et al.
Journal of the National Cancer Institute|June 27, 2024
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapySean J Judge, Parisa Malekzadeh, Marina J Corines, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2009
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumorsOrlo H Clark, Al B Benson, Jordan D Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
ACCO: ASCO core curriculum outlineHyman B Muss, Jamie Von Roenn, Lloyd Earl Damon, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 23, 2008
NCCN Task Force Report: Oral chemotherapySaul N Weingart, Elizabeth Brown, Peter B Bach, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Journal of the National Cancer Institute|August 3, 2023
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancerHagen F Kennecke, Rebecca Auer, May Cho, et al.
Surgical Endoscopy|July 14, 2025
The value of MRI and flexible sigmoidoscopy in detecting tumor regrowth in watch and wait rectal cancer patients undergoing active surveillance after total neoadjuvant therapyTrevor M Yeung, Roni Y Rosen, Aron Bercz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Occult primary cancer clinical practice guidelinesDavid S Ettinger, Juan P Arnoletti, Jon P Gockerman, et al.
Clinical Colorectal Cancer|November 8, 2011
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancerLeonard Saltz, Suprith Badarinath, Shaker Dakhil, et al.
Journal of the National Cancer Institute|June 27, 2024
Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapySean J Judge, Parisa Malekzadeh, Marina J Corines, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2009
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumorsOrlo H Clark, Al B Benson, Jordan D Berlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
ACCO: ASCO core curriculum outlineHyman B Muss, Jamie Von Roenn, Lloyd Earl Damon, et al.
Pageof 17